Duh MS - Search Results

1

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.

Laliberté F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P. Laliberté F, et al. Among authors: duh ms. Menopause. 2011 Oct;18(10):1052-9. doi: 10.1097/gme.0b013e3182175e5c. Menopause. 2011. PMID: 21775912

2

Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve.

Duh MS, Lefebvre P, Fastenau J, Piech CT, Waltzman RJ. Duh MS, et al. Oncologist. 2005 Jun-Jul;10(6):438-48. doi: 10.1634/theoncologist.10-6-438. Oncologist. 2005. PMID: 15967837 Free article.

3

Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.

Campos SM, Duh MS, Lefebvre P, Rosberg J. Campos SM, et al. Among authors: duh ms. J Natl Compr Canc Netw. 2005 Nov;3(6):807-16. doi: 10.6004/jnccn.2005.0049. J Natl Compr Canc Netw. 2005. PMID: 16316616

4

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations.

Lefebvre P, Gosselin A, McKenzie RS, Mody SH, Piech CT, Duh MS. Lefebvre P, et al. Among authors: duh ms. Curr Med Res Opin. 2006 Sep;22(9):1623-31. doi: 10.1185/030079906X120968. Curr Med Res Opin. 2006. PMID: 16968565

5

Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations.

Duh MS, Mody SH, Scott McKenzie R, Lefebvre P, Gosselin A, Tak Piech C. Duh MS, et al. Clin Ther. 2006 Sep;28(9):1443-50. doi: 10.1016/j.clinthera.2006.09.020. Clin Ther. 2006. PMID: 17062316

6

Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.

Lefebvre P, Duh MS, Buteau S, Bookhart B, Mody SH. Lefebvre P, et al. Among authors: duh ms. J Am Soc Nephrol. 2006 Dec;17(12):3497-502. doi: 10.1681/ASN.2006030289. Epub 2006 Nov 2. J Am Soc Nephrol. 2006. PMID: 17082245

7

Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations.

Duh MS, Mody SH, McKenzie RS, Lefebvre P, Gosselin A, Bookhart BK, Piech CT. Duh MS, et al. Drugs Aging. 2006;23(12):969-76. doi: 10.2165/00002512-200623120-00004. Drugs Aging. 2006. PMID: 17154661

8

The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.

Lefebvre P, Duh MS, Mody SH, Bookhart B, Piech CT. Lefebvre P, et al. Among authors: duh ms. Dis Manag. 2007 Feb;10(1):37-45. doi: 10.1089/dis.2006.626. Dis Manag. 2007. PMID: 17309363

9

Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study.

Zilberberg MD, Carter C, Lefebvre P, Raut M, Vekeman F, Duh MS, Shorr AF. Zilberberg MD, et al. Among authors: duh ms. Crit Care. 2007;11(3):R63. doi: 10.1186/cc5934. Crit Care. 2007. PMID: 17553147 Free PMC article.

10

Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?

Wu WK, Duh MS, Lefebvre P. Wu WK, et al. Among authors: duh ms. Hepatology. 2007 Jul;46(1):283; author reply 283-4. doi: 10.1002/hep.21707. Hepatology. 2007. PMID: 17596889 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters